Claudio Nunes

Claudio Nunes serves as CEO at Vigodent-Coltene. Vigodent-Coltene operates in the medical devices sector with approximately 140.0 employees. The company is headquartered in Sao Paulo, State of Sao Paulo.

Industry & Role Insights

• • MessageCEO tracks 1,888 executives in the medical devices sector.
• • 3,750 executive contacts are available in State of Sao Paulo.
• • Our database includes 201,469 c suite-level executives.

Outlook Apache Google translate widget reCAPTCHA WordPress.org Google Font API Google Analytics Facebook Custom Audiences Google Tag Manager Woo Commerce Facebook Widget Facebook Login (Connect) Multilingual YouTube Nginx Mobile Friendly Google translate API Centro

produtos odontologicos medical devices dentistry dental products resin composite aesthetic restoration dental cement flowable resin endodontic instruments dental whitening dental impression dental prosthetics bonding agents ceramic materials polishing systems nanohybrid resin universal composite teeth whitening dental materials clinical solutions orthodontic adhesive dental care dental solutions dental technology dental procedures fillings dental restoration temporary filling material dental equipment dental supplies clinical efficiency patient care dental composites high performance dental precision dentistry professional training dentist support dental hygiene dental manufacturing product features material properties clinical effectiveness restorative dentistry patient safety product innovation dental bonding dental sheaths dental devices fit & finish clinical excellence dental aesthetics high strength resin resin sculpting hospital & health care medical practice

YM

Yahia Megahed CEO at 360Imaging

HA

Hugo Azevedo Chief Technology Officer at 3B Scientific

MP

Marie-Laure Pochon CEO & President at 3DISC

KD

Khanh Duy Co-CEO at 3D-Side

K

Khanh Co-CEO at 3D-Side

Outreach Guidance — medical devices Sector

Executives like Claudio Nunes in the medical devices sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Vigodent-Coltene.

Claudio Nunes's Position in the MessageCEO Database

• •Claudio Nunes is 1 of 1 verified executive contact we track at Vigodent-Coltene.
• •1,787 verified executive contacts in medical devices are in the MessageCEO database.
• •3,723 verified executive contacts in State of Sao Paulo are in the database.
• •34 verified contacts work at medical devices companies in the 140.0 employee range (same size as Vigodent-Coltene).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Claudio Nunes directly?

Claudio Nunes's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Vigodent-Coltene. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Claudio Nunes work for?

Claudio Nunes is CEO at Vigodent-Coltene, a company in the medical devices sector with 140.0 employees. The company is based in Sao Paulo, State of Sao Paulo.

Can I pitch or sell to Claudio Nunes?

As CEO at Vigodent-Coltene, Claudio Nunes is a key decision-maker in the medical devices sector. MessageCEO Pro gives you verified email to reach Claudio Nunes directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Claudio Nunes in?

Claudio Nunes works in the medical devices industry as CEO at Vigodent-Coltene. MessageCEO provides verified contact information for executives across all major industries.

Is Claudio Nunes's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Claudio Nunes's profile is kept up-to-date with the latest available information.

Last updated: June 22, 2026